Antibacterial and anticancer activities of green-synthesized silver nanoparticles using Photinia glabra fruit extract
Abstract
Aims: We prepared Photinia glabra (PG) aqueous fruit extract, utilized it to synthesize silver nanoparticles (PG-Ag NPs) and evaluated the antibacterial and anticancer activities of the nanoparticles (NPs). Materials & methods: Silver nitrate aqueous solution was reduced to PG-Ag NPs using aqueous PG fruit extract. NP shape, size, composition and functionalization were determined using transmission electron microscopy, x-ray photoelectron spectroscopy, Fourier transform infrared and x-ray diffraction. Results & conclusions: PG-Ag NPs were spherical, approximately 39–77 nm-sized, functionalized surfaces with notable antibacterial activity against both Escherichia coli and Staphylococcus aureus, with an MIC <30 ug/ml and cytotoxicity toward esophageal cancer cells, with IC50 values less than 20 ug/ml. PG-Ag@rt NPs have been shown to be a potent antibacterial and anticancer agent, and their enriched particle surfaces can be conjugated with other compounds for multibiomedical applications.
Plain language summary
The present study reports for the first time the preparation of Photinia glabra (PG) aqueous fruit extract and its use for the synthesis of smaller silver particles (PG-Ag NPs) from bulk aqueous silver nitrate solution (AgNO3). The preparation followed the reduction ability of PG fruit extract phytochemical under different preparation conditions: at room temperature (PG-Ag@rt), at 70°C (PG-Ag@70) and in the presence of cerium oxide at 70°C (PG-Ag+CeO2@70). The prepared smaller particles were found using transmission electron microscopy to be spherical in shape with sizes 39, 77 and 44 nm for PG-Ag@rt, PG-Ag@70 and PG-Ag+CeO2@70, respectively. The NPs contained different functional groups on their surfaces due to the capping ability of PG fruit extract components. Among all, PG-Ag@rt NPs showed strongest antibacterial activity against Escherichia coli and Staphylococcus aureus with MIC 7.0 μg/ml and 28.0 μg/ml, respectively, and commendable anticancer activity toward Eca-109 cancer cells with IC50 less than 20 ug/ml.
Papers of special note have been highlighted as: • of interest; •• of considerable interest
References
- 1. . Green synthesis of metallic nanoparticles and their prospective biotechnological applications: an overview. Biol. Trace Element Res. 199(1), 344–370 (2021).
- 2. Bioinspired morphology-controlled silver nanoparticles for antimicrobial application. Mat. Sci. Eng. C. Mat. Biol. Appl. 108, 110421 (2020).
- 3. Solid lipid nanoparticles for targeted natural and synthetic drugs delivery in high-incidence cancers, and other diseases: roles of preparation methods, lipid composition, transitional stability, and release profiles in nanocarriers’ development. Nanotechnol. Rev. 12(1), 1–30 (2023).
- 4. . SPIONs conjugate supported anticancer drug doxorubicin's delivery: current status, challenges, and prospects. Nanomaterials (Basel, Switzerland) 12(20), 3686 (2022).
- 5. . Bacterial resistance to antibiotics: active efflux and reduced uptake. Adv. Drug Deliv. Rev. 57(10), 1486–1513 (2005).
- 6. Efflux pumps: their role in Staphylococcus aureus antibiotic resistance. Ann. Biol. Clin. 66(5), 499–508 (2008).
- 7. . Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps. Int. J. Antimicrob. Agents 33(2), 174–176 (2009).
- 8. . Multidrug evolutionary strategies to reverse antibiotic resistance. Science 351(6268), aad3292 (2016).
- 9. . Antimicrobial resistance: a public health challenge. Med. J. Armed Forces India 71(2), 178–181 (2015).
- 10. . Antimicrobial resistance is a global problem – a UK perspective. Eur. J. Integrat. Med. 36, 101136 (2020).
- 11. . Antimicrobial resistance: it is a global crisis, “a slow tsunami”. Igiene e Sanita Pubblica 75(6), 429–450 (2019).
- 12. . Cancer statistics, 2010. CA Cancer J. Clin. 60(5), 277–300 (2010).
- 13. . Overview of esophageal cancer. Ann. Cardiothorac. Surg. 6(2), 131–136 (2017).
- 14. . Recent advances in oesophageal diseases. Gastroenterol. Hepatol. Bed Bench. 7(3), 186–189 (2014).
- 15. Copper oxide nanoparticle-decorated carbon nanoparticle composite colloidal preparation through laser ablation for antimicrobial and antiproliferative actions against breast cancer cell line, MCF-7. BioMed Res. Int. 2022, 9863616 (2022).
- 16. Modification of SWCNTs with hybrid materials ZnO-Ag and ZnO-Au for enhancing bactericidal activity of phagocytic cells against Escherichia coli through NOX2 pathway. Sci. Rep. 12(1), 17203 (2022).
- 17. . Ciprofloxacin-loaded silver nanoparticles as potent nano-antibiotics against resistant pathogenic bacteria. Nanomaterials (Basel, Switzerland) 12(16), 2808 (2022).
- 18. . Antimicrobial activity of the metals and metal oxide nanoparticles. Mat. Sci. Engin. C. 44, 278–284 (2014).
- 19. . 11 – Metal oxide nanoparticles in biomedical applications. In: Metal Oxide Powder Technol. Metal Oxides. Al-Douri Y (Ed.). Elsevier, 233–251 (2020).
- 20. . Plasma-enhanced deposition of silver nanoparticles onto polymer and metal surfaces for the generation of antimicrobial characteristics. J. Appl. Polym. Sci. 93, 1411–1422 (2004).
- 21. . Direct formation of silver nanoparticles in cuttlebone-derived organic matrix for catalytic applications. Colloid. Surf. A: Physicochem. Engin. Aspects 330(2), 234–240 (2008).
- 22. . Enhanced antibacterial and anti-biofilm activities of silver nanoparticles against Gram-negative and Gram-positive bacteria. Nanoscale Res. Letters 9(1), 373 (2014).
- 23. . Enhanced antibacterial and anti-biofilm activities of antimicrobial peptides modified silver nanoparticles. Int. J. Nanomed. 16, 4831–4846 (2021).
- 24. Silver nanoparticles biocomposite films with antimicrobial activity: in vitro and in vivo tests. Int. J. Mol. Sci. 23(18), 10671 (2022).
- 25. . Polyhedral silver nanocrystals with distinct scattering signatures. Angew. Chem. 45(28), 4597–4601 (2006).
- 26. . Generation of nanometer-size fullerene particles via vapor condensation. Chem. Phys. Letters 218(4), 304–308 (1994).
- 27. . Synthesis of silver/montmorillonite nanocomposites using γ-irradiation. Int. J. Nanomed. 5, 1067–1077 (2010).
- 28. . Polymer stabilized silver nanoparticles: a photochemical synthesis route. J. Mater. Sci. 39(14), 4459–4463 (2004).
- 29. . Shape-controlled synthesis of metal nanostructures: the case of silver. Chemistry 11(2), 454–463 (2005).
- 30. . The synthesis of nickel nanoparticles by hydrazine reduction. Adv. Powder Technol. 21(2), 165–168 (2010).
- 31. . Size control over spherical silver nanoparticles by ascorbic acid reduction. Colloid. Surf. A: Physicochem. Engin. Aspects 372(1), 172–176 (2010).
- 32. Fabrication of porous chitosan films impregnated with silver nanoparticles: a facile approach for superior antibacterial application. Colloid. Surf. B: Biointerfaces 76(1), 248–258 (2010).
- 33. . Bioreduction mechanism of silver nanoparticles. Mater. Sci. Eng.: C 107, 110299 (2020).
- 34. . Silver nanoparticles: synthesis, characterization, properties, applications, and therapeutic approaches. Int. J. Mol. Sci. 17(9), 1534 (2016).
- 35. . Green chemistry approach for the synthesis of biocompatible graphene. Int. J. Nanomed. 8, 2719–2732 (2013).
- 36. Biosynthesis, purification and characterization of silver nanoparticles using Escherichia coli. Colloid. Surf. B: Biointerfaces 74(1), 328–335 (2009).
- 37. . Silver-based crystalline nanoparticles, microbially fabricated. Proc. Natl Acad. Sci. USA 96(24), 13611–13614 (1999).
- 38. . Coalescence of nanoclusters and formation of submicron crystallites assisted by Lactobacillus strains. Crystal Growth Design 2(4), 293–298 (2002).
- 39. . Growing metal nanoparticles by enzymes. Adv. Mat. 18(9), 1109–1120 (2006).
- 40. . Plant extract mediated synthesis of silver and gold nanoparticles and its antibacterial activity against clinically isolated pathogens. Colloid. Surf. B: Biointerfaces 85(2), 360–365 (2011).
- 41. . Biosynthesis of silver nanoparticles from Tribulus terrestris and its antimicrobial activity: a novel biological approach. Colloid. Surf. B: Biointerfaces 96, 69–74 (2012).
- 42. Plant extract: a promising biomatrix for ecofriendly, controlled synthesis of silver nanoparticles. Appl. Biochem. Biotechnol. 173(1), 1–29 (2014). • Demonstrates the possibility of controlled synthesis of silver nanoparticles using plant extracts and its ecofriendliness.
- 43. . Cassia fistula nutrition rich flower tea derived biotic nanoparticles synthesis, characterization and their antioxidant and anti-hyperglycaemic properties. Afr. Health Sci. 22(1), 384–394 (2022).
- 44. . Antimicrobial activity of silver and gold nanoparticles prepared by photoreduction process with leaves and fruit extracts of Plinia cauliflora and Punica granatum. Molecules (Basel, Switzerland) 27(20), 6860 (2022).
- 45. . Parthenium leaf extract mediated synthesis of silver nanoparticles: a novel approach towards weed utilization. Dig. J. Nanomat. Biostruct. 4(1), 45–50 (2009).
- 46. Enhanced antimicrobial and anticancer activity of silver and gold nanoparticles synthesised using Sargassum incisifolium aqueous extracts. Molecules (Basel, Switzerland) 21(12), 1633 (2016).
- 47. One-pot green synthesis and structural characterisation of silver nanoparticles using aqueous leaves extract of Carissa carandas: antioxidant, anticancer and antibacterial activities. IET Nanobiotechnol. 12(6), 748–756 (2018).
- 48. . Synthesis of silver nanoparticles by Phoma gardeniae and in vitro evaluation of their efficacy against human disease-causing bacteria and fungi. IET Nanobiotechnol. 9(2), 71–75 (2015).
- 49. In vivo antimicrobial activity of silver nanoparticles produced via a green chemistry synthesis using Acacia rigidula as a reducing and capping agent. Int. J. Nanomed. 13, 2349–2363 (2018).
- 50. Coated silver nanoparticles: synthesis, cytotoxicity, and optical properties. RSC Adv. 9(35), 20118–20136 (2019).
- 51. . Green synthesis and characterization of silver nanoparticle using leaf extract of Capparis zeylanica. Asian J. Pharmaceut. Clin. Res. 7, 44–48 (2014).
- 52. . Photodynamic therapy: a compendium of latest reviews. Cancers (Basel) 13(17), 4447 (2021).
- 53. . Salt-tolerant plants, halophytes, as renewable natural resources for cancer prevention and treatment: roles of phenolics and flavonoids in immunomodulation and suppression of oxidative stress towards cancer management. Int. J. Mol. Sci. 24(6), 5171 (2023).
- 54. Construction and function of robust and moist bilayer chitosan-based hydrogel wound dressing. Mat. Design 226, 111604 (2023).
- 55. . Green synthesis of silver nanoparticles using methanolic fruit extract of Aegle marmelos and their antimicrobial potential against human bacterial pathogens. J. Trad. Complement. Med. 10(2), 158–165 (2020).
- 56. . Green synthesis of silver nanoparticles from peel extract of Chrysophyllum albidum fruit and their antimicrobial synergistic potentials and biofilm inhibition properties. BioMetals 1–12,
doi:10.1007/s10534-022-00483-5 (2022). - 57. . Green synthesis of silver nanoparticles by using carambola fruit extract and their antibacterial activity. Adv. Nat. Sci. Nanosci. Nanotechnol. 6, 045015 (2015).
- 58. . Synthesis of colloidal silver nanoparticles by reducing aqueous AgNO3 using green reducing agents. Mat. Today Proc. 5, 10054–10061 (2018).
- 59. . In vitro and in vivo synergistic wound healing and anti-methicillin-resistant Staphylococcus aureus (MRSA) evaluation of liquorice-decorated silver nanoparticles. J. Antibiotics 76(5), 291–300 (2023).
- 60. Green synthesis of silver nanoparticles using Lysiloma acapulcensis exhibit high-antimicrobial activity. Sci. Rep. 10(1), 12805 (2020). •• Demonstrates the potential of green-synthesized silver nanoparticles as antimicrobial agents.
- 61. . Antibacterial activity and characteristics of silver nanoparticles biosynthesized from Carduus crispus. Sci. Rep. 11(1), 21047 (2021).
- 62. Antimicrobial and cytotoxic activity of green synthesis silver nanoparticles targeting skin and soft tissue infectious agents. Sci. Rep. 11(1), 14566 (2021).
- 63. In vitro antimicrobial activity of green synthesized silver nanoparticles against selected Gram-negative foodborne pathogens. Front. Microbiol. 9, 1555 (2018).
- 64. Biogenic synthesis of metal nanoparticles using a biosurfactant extracted from corn and their antimicrobial properties. Nanomaterials 7, 139 (2017).
- 65. . Preliminary phytochemical screening of six medicinal plants used in traditional medicine. Int. J. Pharmacy Pharmaceut. Sci. 6, 539–542 (2014).
- 66. . Preliminary phytochemical and elemental analysis of aqueous and fractionated pod extracts of Acacia nilotica (thorn mimosa). Vet. Res. Forum 5(2), 95–100 (2014).
- 67. . Study on the inhibitory effects of Korean medicinal plants and their main compounds on the 1,1-diphenyl-2-picrylhydrazyl radical. Phytomed.: Int. J. Phytother. Phytopharmacol. 10(6-7), 544–551 (2003).
- 68. Competitive-type pressure-dependent immunosensor for highly sensitive detection of diacetoxyscirpenol in wheat via monoclonal antibody. Analyt. Chem. 92(5), 3563–3571 (2020).
- 69. . Green synthesized silver nanoparticles: antibacterial and anticancer activities, biocompatibility, and analyses of surface-attached proteins. Front. Microbiol. 12, 632505 (2021). • Demonstrates the potential of green-synthesized silver nanoparticles as anticancer agents.
- 70. Functionalization of aminoalkylsilane-grafted bacterial nanocellulose with ZnO-NPs-doped pullulan electrospun nanofibers for multifunctional wound dressing. ACS Biomater. Sci. Eng. 7(8), 3933–3946 (2021).
- 71. . Agar well diffusion assay testing of bacterial susceptibility to various antimicrobials in concentrations non-toxic for human cells in culture. Burns: J. Int. Soc. Burn Inj. 20(5), 426–429 (1994). • Reports on the use of Agar well diffusion assay for bacterial susceptibility for nanomaterials.
- 72. . Screening methods to determine antibacterial activity of natural products. Braz. J. Microbiol. 38, 369–380 (2007). •• Shows preliminary test procedures for natural products and their antibacterial activity.
- 73. . Sunlight-driven wearable and robust antibacterial coatings with water-soluble cellulose-based photosensitizers. Adv. Healthc. Mater. 8(5), e1801591 (2019).
- 74. . Synthesis and characterization of antibacterial dental monomers and composites. J. Biomed. Mater. Res. Part B. Appl. Biomater. 100, 1151–1162 (2012).
- 75. A poly-l-lysine-bonded TEMPO-oxidized bacterial nanocellulose-based antibacterial dressing for infected wound treatment. Carbohydr. Polym. 287, 119266 (2022). • Shows step-wise precise procedure for Luria-Bertani medium preparation and direct contact antibacterial testing method.
- 76. Biosynthesis and antibacterial activity of silver nanoparticles using yeast extract as reducing and capping agents. Nanoscale Res. Lett. 15, Article 14 (2020).
- 77. A novel lead compound CM-118: antitumor activity and new insight into the molecular mechanism and combination therapy strategy in c-Met- and ALK-dependent cancers. Cancer Biol. Ther. 15(6), 721–734 (2014).
- 78. . Evaluation of antioxidant and anticancer activity of copper oxide nanoparticles synthesized using medicinally important plant extracts. Biomed. Pharmacother. 89, 1067–1077 (2017).
- 79. . Phototoxicity of zinc oxide nanoparticle conjugatesin human ovarian cancer NIH: OVCAR-3 cells. J. Biomed. Nanotechnol. 4, 432–438 (2008).
- 80. Green synthesis of silver nanoparticles using fruits extracts of Syzygium cumini and their bioactivity. Chem. Phys. Lett. 795, 139493 (2022).
- 81. . Biosynthesis of silver nanoparticles using dried fruit extract of Ficus carica – screening for its anticancer activity and toxicity in animal models. Food Chem. Toxicol. 109(Pt 2), 951–956 (2017). • Demonstrates the possibility of using fruit extracts as reducing and capping agents for green synthesis of silver nanoparticles.
- 82. Fruit extract mediated green synthesis of metallic nanoparticles: a new avenue in pomology applications. Int. J. Mol. Sci. 21(22), 8458 (2020).
- 83. . Green synthesis of silver nanoparticles by using carambola fruit extract and their antibacterial activity. Adv. Nat. Sci.: Nanosci. Nanotechnol. 6(4), 045015 (2015).
- 84. . Green synthesis of silver nanoparticles: characterization and determination of antibacterial potency. Appl. Nanosci. 6(2), 259–265 (2016).
- 85. . Phytosynthesis of silver nanoparticles using perilla frutescens leaf extract: characterization and evaluation of antibacterial, antioxidant, and anticancer activities. Int. J. Nanomed. 16, 15–29 (2021).
- 86. . Characteristics and occurrence of phenolic phytochemicals. J. Am. Dietetic Assoc. 99(2), 213–218 (1999).
- 87. . A study on the stability and green synthesis of silver nanoparticles using Ziziphora tenuior (Zt) extract at room temperature. Spectrochim. Acta A. Mol. Biomol. Spectrosc. 134, 310–315 (2015). •• Demonstrates the possibility of controlled synthesis of silver nanoparticles at room temperature using plant extracts.
- 88. . Synthesis of silver nanoparticles by using tea leaf extract from Camellia sinensis. Int. J. Nanomed. 7, 4263–4267 (2012).
- 89. A comparative study of silver nanoparticles synthesized by arc discharge and femtosecond laser ablation in aqueous solution. Appl. Phys. A 122, 896 (2016).
- 90. . Molecular mechanisms of Chlamydia trachomatis resistance to antimicrobial drugs. Front. Biosci. 23(4), 656–670 (2018).
- 91. . Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report. J. Infect. Dis. 191(6), 917–923 (2005).
- 92. Membrane-targeting neolignan-antimicrobial peptide mimic conjugates to combat methicillin-resistant Staphylococcus aureus (MRSA) infections. J. Medicin. Chem. 65(24), 16879–16892 (2022).
- 93. A neglected risk of nanoplastics as revealed by the promoted transformation of plasmid-borne ampicillin resistance gene by Escherichia coli. Environment. Microbiol. 24(10), 4946–4959 (2022).
- 94. . Low hazard of silver nanoparticles and silver nitrate to the haematopoietic system of rainbow trout. Ecotoxicol. Environment. Safe. 152, 121–131 (2018).
- 95. . A new report of Nocardiopsis valliformis strain OT1 from alkaline Lonar crater of India and its use in synthesis of silver nanoparticles with special reference to evaluation of antibacterial activity and cytotoxicity. Med. Microbiol. Immunol. 205(5), 435–447 (2016).
- 96. . Antibiofilm, antimicrobial and cytotoxic activity of extracellular green-synthesized silver nanoparticles by two marine-derived actinomycete. RSC Adv. 10(17), 10361–10367 (2020).